Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eton Pharmaceutcials Inc (NQ: ETON )

3.900 +0.040 (+1.04%)
Streaming Delayed Price Updated: 10:41 AM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,080
Open 3.900
Bid (Size) 3.880 (1)
Ask (Size) 3.900 (3)
Prev. Close 3.860
Today's Range 3.900 - 3.900
52wk Range 1.950 - 4.280
Shares Outstanding 25,504,378
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Eton Pharmaceuticals Q1 Earnings
 
Via Benzinga
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire

Performance

YTD
+34.95%
+34.95%
1 Month
+12.39%
+12.39%
3 Month
N/A
N/A
6 Month
+32.20%
+32.20%
1 Year
+30.00%
+30.00%

More News

Read More
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Looking Into Eton Pharmaceuticals's Return On Capital Employed
Via Benzinga
A Preview Of Eton Pharmaceuticals's Earnings
Via Benzinga
Looking Into Eton Pharmaceuticals's Return On Capital Employed
Via Benzinga
Recap: Eton Pharmaceuticals Q2 Earnings
Via Benzinga
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
From Eton Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
From Eton Pharmaceuticals
Via GlobeNewswire
Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Looking Into Eton Pharmaceuticals's Return On Capital Employed
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Eton Pharmaceuticals (ETON) Stock Is Up 10% on FDA Approval
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.